237 related articles for article (PubMed ID: 35883603)
21. Identification of uterine leiomyosarcoma-associated hub genes and immune cell infiltration pattern using weighted co-expression network analysis and CIBERSORT algorithm.
Shen X; Yang Z; Feng S; Li Y
World J Surg Oncol; 2021 Jul; 19(1):223. PubMed ID: 34321013
[TBL] [Abstract][Full Text] [Related]
22. Clinical Benefit in Response to Palbociclib Treatment in Refractory Uterine Leiomyosarcomas with a Common
Elvin JA; Gay LM; Ort R; Shuluk J; Long J; Shelley L; Lee R; Chalmers ZR; Frampton GM; Ali SM; Schrock AB; Miller VA; Stephens PJ; Ross JS; Frank R
Oncologist; 2017 Apr; 22(4):416-421. PubMed ID: 28283584
[TBL] [Abstract][Full Text] [Related]
23. A differentiation-based microRNA signature identifies leiomyosarcoma as a mesenchymal stem cell-related malignancy.
Danielson LS; Menendez S; Attolini CS; Guijarro MV; Bisogna M; Wei J; Socci ND; Levine DA; Michor F; Hernando E
Am J Pathol; 2010 Aug; 177(2):908-17. PubMed ID: 20558575
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic and prognostic value of Bcl-2 in uterine leiomyosarcoma.
Travaglino A; Raffone A; Raimondo D; Gencarelli A; Esposito I; Gallo C; Improda FP; Vitale SG; Mollo A; Casadio P; Seracchioli R; Zullo F; Insabato L
Arch Gynecol Obstet; 2023 Feb; 307(2):379-386. PubMed ID: 35344084
[TBL] [Abstract][Full Text] [Related]
25. Preoperative clinical characteristics scoring system for differentiating uterine leiomyosarcoma from fibroid.
Zhang G; Yu X; Zhu L; Fan Q; Shi H; Lang J
BMC Cancer; 2020 Jun; 20(1):514. PubMed ID: 32493236
[TBL] [Abstract][Full Text] [Related]
26.
Seligson ND; Kautto EA; Passen EN; Stets C; Toland AE; Millis SZ; Meyer CF; Hays JL; Chen JL
Oncologist; 2019 Jul; 24(7):973-979. PubMed ID: 30541756
[TBL] [Abstract][Full Text] [Related]
27. Let-7 repression leads to HMGA2 overexpression in uterine leiomyosarcoma.
Shi G; Perle MA; Mittal K; Chen H; Zou X; Narita M; Hernando E; Lee P; Wei JJ
J Cell Mol Med; 2009 Sep; 13(9B):3898-905. PubMed ID: 19602040
[TBL] [Abstract][Full Text] [Related]
28. p53, epidermal growth factor, and platelet-derived growth factor in uterine leiomyosarcoma and leiomyomas.
Anderson SE; Nonaka D; Chuai S; Olshen AB; Chi D; Sabbatini P; Soslow RA
Int J Gynecol Cancer; 2006; 16(2):849-53. PubMed ID: 16681772
[TBL] [Abstract][Full Text] [Related]
29. Potential Markers to Differentiate Uterine Leiomyosarcomas from Leiomyomas.
Guo J; Zheng J; Tong J
Int J Med Sci; 2024; 21(7):1227-1240. PubMed ID: 38818470
[TBL] [Abstract][Full Text] [Related]
30. Novel therapeutic strategies targeting UCP2 in uterine leiomyosarcoma.
Nagao Y; Yokoi A; Yoshida K; Sugiyama M; Watanabe E; Nakamura K; Kitagawa M; Asano-Inami E; Koya Y; Yoshihara M; Tamauchi S; Shimizu Y; Ikeda Y; Yoshikawa N; Kato T; Yamamoto Y; Kajiyama H
Pharmacol Res; 2023 Mar; 189():106693. PubMed ID: 36773710
[TBL] [Abstract][Full Text] [Related]
31. H3K4me3 mediates uterine leiomyoma pathogenesis via neuronal processes, synapsis components, proliferation, and Wnt/β-catenin and TGF-β pathways.
Carbajo-García MC; Juarez-Barber E; Segura-Benítez M; Faus A; Trelis A; Monleón J; Carmona-Antoñanzas G; Pellicer A; Flanagan JM; Ferrero H
Reprod Biol Endocrinol; 2023 Jan; 21(1):9. PubMed ID: 36703136
[TBL] [Abstract][Full Text] [Related]
32. Bromodomain-containing protein 9 promotes hepatocellular carcinoma progression via activating the Wnt/β-catenin signaling pathway.
Fang D; Wang MR; Guan JL; Han YY; Sheng JQ; Tian DA; Li PY
Exp Cell Res; 2021 Sep; 406(2):112727. PubMed ID: 34370992
[TBL] [Abstract][Full Text] [Related]
33. Cyclin-dependent kinase subunit 2 overexpression promotes tumor progression and predicts poor prognosis in uterine leiomyosarcoma.
Deng Y; Han Q; Mei S; Li H; Yang F; Wang J; Ge S; Jing X; Xu H; Zhang T
Oncol Lett; 2019 Sep; 18(3):2845-2852. PubMed ID: 31452763
[TBL] [Abstract][Full Text] [Related]
34. Molecular cytogenetic analysis of uterine leiomyoma and leiomyosarcoma by comparative genomic hybridization.
Levy B; Mukherjee T; Hirschhorn K
Cancer Genet Cytogenet; 2000 Aug; 121(1):1-8. PubMed ID: 10958933
[TBL] [Abstract][Full Text] [Related]
35. Elimusertib (BAY1895344), a novel ATR inhibitor, demonstrates in vivo activity in ATRX mutated models of uterine leiomyosarcoma.
Harold J; Bellone S; Manavella DD; Mutlu L; McNamara B; Hartwich TMP; Zipponi M; Yang-Hartwich Y; Demirkiran C; Verzosa MS; Choi J; Dong W; Buza N; Hui P; Altwerger G; Huang GS; Andikyan V; Clark M; Ratner E; Azodi M; Schwartz PE; Santin AD
Gynecol Oncol; 2023 Jan; 168():157-165. PubMed ID: 36442427
[TBL] [Abstract][Full Text] [Related]
36. DPP6 and MFAP5 are associated with immune infiltration as diagnostic biomarkers in distinguishing uterine leiomyosarcoma from leiomyoma.
Ke Y; You L; Xu Y; Wu D; Lin Q; Wu Z
Front Oncol; 2022; 12():1084192. PubMed ID: 36531033
[TBL] [Abstract][Full Text] [Related]
37. The value of re-exploration in patients with inadvertently morcellated uterine sarcoma.
Oduyebo T; Rauh-Hain AJ; Meserve EE; Seidman MA; Hinchcliff E; George S; Quade B; Nucci MR; Del Carmen MG; Muto MG
Gynecol Oncol; 2014 Feb; 132(2):360-5. PubMed ID: 24296345
[TBL] [Abstract][Full Text] [Related]
38. [The loss of heterozygosity and microsatellite instability analysis in differential diagnostics of leiomyosarcoma and proliferative leiomyoma of the uterus].
Shikeeva AA; Kekeeva TV; Zavalishina LÉ; Andreeva IuIu; Frank GA
Arkh Patol; 2011; 73(4):47-50. PubMed ID: 22164433
[TBL] [Abstract][Full Text] [Related]
39. Uterine leiomyosarcomas harboring MAP2K4 gene amplification are sensitive in vivo to PLX8725, a novel MAP2K4 inhibitor.
McNamara B; Harold J; Manavella D; Bellone S; Mutlu L; Hartwich TMP; Zipponi M; Yang-Hartwich Y; Demirkiran C; Verzosa MSZ; Yang K; Choi J; Dong W; Buza N; Hui P; Altwerger G; Huang GS; Andikyan V; Clark M; Ratner E; Azodi M; Schwartz PE; Burton EA; Inagaki H; Albers A; Zhang C; Bollag G; Schlessinger J; Santin AD
Gynecol Oncol; 2023 May; 172():65-71. PubMed ID: 36958197
[TBL] [Abstract][Full Text] [Related]
40. Uterine leiomyosarcoma cell-derived extracellular vesicles induce the formation of cancer-associated fibroblasts.
Nagao Y; Yokoi A; Yoshida K; Kitagawa M; Asano-Inami E; Kato T; Ishikawa M; Yamamoto Y; Kajiyama H
Biochim Biophys Acta Mol Basis Dis; 2024 Apr; 1870(4):167103. PubMed ID: 38417460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
